Olanzapine: all 266 studies that test it
Page 1 of 3. Open to participants first (22), then studies with results posted, then the rest; newest registration first within each.
- Olanzapine in the Prevention and Treatment of Anorexia-Cachexia Syndrome in Patients Receiving Neoadjuvant/Preoperative ChemotherapyRecruitingNCT07633236Phase 3
- GI-05: The Impact of Olanzapine Among Patients Receiving Neoadjuvant Chemotherapy for Gastric CancerNot yet recruitingNCT07581405Phase 2
- Study to Evaluate Efficacy and Safety of Roluperidone in Adult Subjects With Negative Symptoms and Stable Positive Symptoms of Schizophrenia and to Evaluate the Relapse Rate of Roluperidone and Antipsychotic MedicationsRecruitingNCT07565428Phase 3
- An Exploratory Study on Efficacy and Safety of Fosaprepitant and Palonosetron Hydrochloride for Injection in Preventing CINV From Multi-Agent HECRecruitingNCT07482891Phase 4
- A Cohort Study on the Prevention of Nausea and Vomiting Induced by Concurrent Chemoradiotherapy for Lung Cancer Using Rolapitant and PalonosetronNot yet recruitingNCT07442890Not applicable
- Prevention of Delayed CINV After Autologous Transplant: Olanzapine-Containing Regimen vs. Dexamethasone-Containing RegimenRecruitingNCT07413809Phase 3
- Olanzapine Plus Metoclopramide for the Prevention of Opioid-Induced Nausea and VomitingRecruitingNCT07208305Phase 3
- Olanzapine for Prevention of Vomiting in Children and Adolescents Receiving Highly Emetogenic ChemotherapyNot yet recruitingNCT07035821Phase 3
- Olanzapine for Managing Anorexia in Head and Neck Cancer Patients Undergoing Chemoradiation, MACRO TrialRecruitingNCT06995508Phase 2
- Olanzapine Versus Placebo for Moderately Emetogenic ChemotherapyRecruitingNCT06850454Phase 3
- Olanzapine 2.5 vs 5 mg in Quadruplet Nausea/Vomiting Prophylaxis Before High-Dose MelphalanRecruitingNCT06588413Phase 3
- Olanzapine Impact on First-line Immunotherapy for Advanced EGFR-negative NSCLCRecruitingNCT06554613Phase 2
- Olanzapine for Cancer Related Anorexia-cachexia SyndromeRecruitingNCT06517199Phase 3
- Nutrition Impact on Immunotherapy of CancerRecruitingNCT06500234Phase 3
- Survival With Olanzapine in Patients With Locally Advanced or Metastatic Upper Gastrointestinal and Lung CancerRecruitingNCT06338683Phase 3
- The Danish Out-of-Hospital Cardiac Arrest StudyRecruitingNCT05895838Phase 3
- Sequenced Treatment Alternatives to Relieve Adolescent Depression (STAR-AD)RecruitingNCT05814640Phase 1/2
- Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung CancerRecruitingNCT05705492Phase 2
- Dexamethasone, Olanzapine, Hemodynamics, and Ventilation in Cardiac SurgeryRecruitingNCT05635227Not applicable
- Comparing Olanzapine and Mirtazapine in the Improvement of Unintentional Weight Loss for Patients with Advanced Stage CancerEnrolling by invitationNCT05170919Phase 2
- Long-term Safety Extension Study of OLZ/SAM in Pediatric SubjectsEnrolling by invitationNCT04987229Phase 3
- "Extended" (Alternate Day) Antipsychotic DosingRecruitingNCT04478838Phase 4
- Open-label Trial Characterizing the PK of 3 SC Olanzapine Extended-release Formulations in Participants With Schizophrenia/Schizoaffective DisorderCompletedNCT06319170Phase 1Results posted
- Safety, Tolerability, and Pharmacokinetic Study of TV-44749 in Chinese Patients With SchizophreniaCompletedNCT06253546Phase 1Results posted
- Pediatric Oncology Nutrition Intervention TrialCompletedNCT06175273Phase 2/3Results posted
- A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Co-Administration of Roluperidone and Olanzapine in Adult Subjects With Moderate to Severe Negative Symptoms of SchizophreniaCompletedNCT06107803Phase 1Results posted
- The Impact of Preoperative Olanzapine on Quality of Recovery After Discharge From Ambulatory SurgeryCompletedNCT05676294Phase 2Results posted
- Steroid-sparing Therapy (Olanzapine) Versus Dexamethasone-based Therapy for Chemotherapy-induced Nausea and VomitingTerminatedNCT05590923Phase 4Results posted
- Olanzapine for Nausea/Vomiting Prophylaxis in Recipients of Hematopoietic Stem Cell TransplantsCompletedNCT04535141Phase 3Results posted
- Olanzapine for the Prevention of Chemotherapy Induced Nausea and Vomiting in Gynecologic Oncology PatientsTerminatedNCT04503668Phase 3Results posted
- A Trial to Explore Acceptance and Performance of Using a Digital Medicine System With Healthcare Professionals and Adults With Schizophrenia, Schizoaffective Disorder, or First Episode Psychosis on an Oral Atypical AntipsychoticCompletedNCT03568500Phase 4Results posted
- Treatment of Refractory Nausea and Vomiting in Patients With Breast CancerCompletedNCT03367572Phase 3Results posted
- Efficacy of Lu AF35700 in Patients With Early-in-disease or Late-in-disease Treatment-resistant SchizophreniaTerminatedNCT03230864Phase 3Results posted
- Study to Evaluate the Long-term Safety, Tolerability, and Durability of Treatment Effect of ALKS 3831CompletedNCT03201757Phase 3Results posted
- Study to Evaluate the Efficacy of ALKS 3831 on Body Weight in Young Adults Who Have Been Recently Diagnosed With Schizophrenia, Schizophreniform, or Bipolar I DisorderCompletedNCT03187769Phase 3Results posted
- Olanzapine for the Treatment of Chronic Nausea and/or Vomiting in Advanced Cancer PatientsCompletedNCT03137121Phase 2/3Results posted
- Olanzapine for Acute HeadachesCompletedNCT03066622Phase 4Results posted
- Aprepitant- and Olanzapine- Containing Anti-emetic Regimens With High Dose MelphalanCompletedNCT02939287Phase 3Results posted
- A Phase 3, Long-term Safety and Tolerability Study of ALKS 3831 in Adults With SchizophreniaCompletedNCT02873208Phase 3Results posted
- Olanzapine for Nausea After SurgeryCompletedNCT02755116Phase 2Results posted
- Effect of Lu AF35700 in Patients With Treatment-resistant SchizophreniaCompletedNCT02717195Phase 3Results posted
- A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)CompletedNCT02694328Phase 3Results posted
- A Long-Term Safety and Tolerability Study of ALKS 3831 in Adults With SchizophreniaCompletedNCT02669758Phase 3Results posted
- Utility of Olanzapine in the Treatment of Opioid Withdrawal in the EDCompletedNCT02643355Not applicableResults posted
- Study of FOND Versus FOND+O for the Prevention of CINV in Hematology Patients Receiving Highly Emetogenic Chemotherapy RegimensCompletedNCT02635984Phase 3Results posted
- The Effects of Antipsychotic Drugs on Brain Metabolism in Healthy IndividualsCompletedNCT02536846Phase 4Results posted
- Aprepitant ,Olanzapine,Palonosetron and Dexamethasone for the Prevention of Chemotherapy-induced Nausea and VomitingCompletedNCT02484911Phase 3Results posted
- A Study to Assess the Clinical Utility of Antipsychotic Medication Levels in Plasma as Determined by Liquid Chromatography-Tandem Mass SpectrometryTerminatedNCT02462473Phase 2Results posted
- A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use DisorderCompletedNCT02161718Phase 2Results posted
- Olanzapine for Prevention of Chemotherapy-induced Nausea and Vomiting in Children: A Multi-Centre Feasibility StudyCompletedNCT02129478Phase 2Results posted
- Antiemetic Therapy With or Without Olanzapine in Preventing Chemotherapy-Induced Nausea and Vomiting in Patients With Cancer Receiving Highly Emetogenic ChemotherapyCompletedNCT02116530Phase 3Results posted
- Pilot Study of Olanzapine and Aprepitant to Prevent Nausea and Vomiting in Children Receiving ChemotherapyCompletedNCT02097823Phase 2Results posted
- Assessment and Comparison of Metabolic Changes in Non-psychotic Adults Taking Iloperidone or Olanzapine or PlaceboCompletedNCT01920802Phase 4Results posted
- A Study of Olanzapine and Fluoxetine for Treatment-resistant DepressionTerminatedNCT01687478Phase 3Results posted
- A Pilot Study on the Efficacy and Safety of Olanzapine in GastroparesisTerminatedNCT01625923Not applicableResults posted
- Metabolic Effects of Olanzapine in Healthy MalesCompletedNCT01496183Not applicableResults posted
- Sustaining Remission of Psychotic DepressionCompletedNCT01427608Phase 4Results posted
- Olanzapine Versus Placebo for Outpatients With Anorexia NervosaCompletedNCT01170117Not applicableResults posted
- A Study of Olanzapine in Patients With SchizophreniaCompletedNCT00970281Phase 3Results posted
- Examining the Effects of Antipsychotic Medications on Insulin SensitivityCompletedNCT00895921Phase 4Results posted
- Comparison of Optimal Antipsychotic Treatments for Adults With SchizophreniaCompletedNCT00802100Phase 4Results posted
- Intramuscular (IM) Olanzapine Versus IM Haloperidol Plus Lorazepam for Acute Agitation in SchizophreniaCompletedNCT00797277Phase 3Results posted
- A New Pharmacotherapy for Alcohol Dependence: OlanzapineCompletedNCT00746785Phase 3Results posted
- A Crossover Study of the Acute Effects of Olanzapine in Healthy VolunteersCompletedNCT00741026Not applicableResults posted
- Effectiveness of Olanzapine Versus Placebo in Treating Outpatients With Anorexia NervosaCompletedNCT00692185Phase 2Results posted
- Effectiveness of Atypical Antipsychotic Medication for Outpatients With Anorexia NervosaCompletedNCT00685334Phase 4Results posted
- A Study Comparing Rapid Acting Intramuscular Olanzapine and Placebo in Agitated Patients With SchizophreniaCompletedNCT00640510Phase 3Results posted
- Safety and Efficacy of Olanzapine in the Long-term Treatment for Bipolar I Disorder, DepressedCompletedNCT00618748Phase 3Results posted
- Glucose and Lipid Metabolism on Antipsychotic MedicationCompletedNCT00515723Not applicableResults posted
- Melatonin Metabolism Abnormality in Patients With Schizophrenia or Schizoaffective Disorder Treated With OlanzapineCompletedNCT00512070Not applicableResults posted
- Olanzapine Treatment of Patients With Bipolar I DisorderCompletedNCT00510146Phase 3Results posted
- Diabetes in Neuropsychiatric DisordersCompletedNCT00446992Phase 1/2Results posted
- A Comparison of Olanzapine in Combination With a Mood Stabilizer vs Mood Stabilizer Alone, in Mixed Bipolar PatientsCompletedNCT00402324Phase 4Results posted
- Medication, Weight Gain and GI HormonesCompletedNCT00384332Phase 4Results posted
- Efficacy Study of Early Onset of Antipsychotic Drug Action in SchizophreniaCompletedNCT00337662Phase 4Results posted
- Comparing the Effect of Under the Tongue Olanzapine Versus Swallowed Olanzapine on Body Mass Index (A Ratio of Weight to Height)CompletedNCT00303602Phase 4Results posted
- PET Imaging and Olanzapine Treatment in Borderline Personality DisorderCompletedNCT00275301Not applicableResults posted
- Olanzapine in the Treatment of Patients With Anorexia NervosaCompletedNCT00260962Phase 2Results posted
- Validation of Multidimensional Assessment of THYmic States (MATHYS): A Study in a Population of Bipolar Patients Treated With OlanzapineCompletedNCT00259272Phase 3Results posted
- Metabolic Effects of Antipsychotics in ChildrenCompletedNCT00205699Phase 4Results posted
- Safety Study of Olanzapine and a Comparator in Patients With Schizophrenia and Schizoaffective DisorderCompletedNCT00190749Phase 4Results posted
- Short Term Rescue Study of OlanzapineCompletedNCT00186017Phase 4Results posted
- Supported Employment and Skills Training in Conjunction With Pharmacotherapy in Schizophrenia PatientsCompletedNCT00183625Phase 4Results posted
- Trial of Olanzapine in Patients With Manic or Mixed Episode of Bipolar I DisorderCompletedNCT00129220Phase 3Results posted
- Open-Label Study of Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective DisorderCompletedNCT00088465Phase 3Results posted
- Treatment of Early Onset Schizophrenia Spectrum Disorders (TEOSS)CompletedNCT00053703Phase 4Results posted
- Switching Medication to Treat SchizophreniaCompletedNCT00044655Phase 4Results posted
- Comparison of Clozapine vs Olanzapine in Childhood-Onset Psychotic DisordersCompletedNCT00001656Phase 4Results posted
- Fosrolapitant and Palonosetron for Highly Emetogenic ADC-Induced Nausea and Vomiting in Solid TumorsActive, not recruitingNCT07841210Phase 2
- Treatment of Tinnitus With OlanzapineCompletedNCT07190482Phase 1
- A Study of Olanzapine After Intranasal and Intramuscular AdministrationCompletedNCT06600477Phase 1
- Detoxification From the Lipid TractCompletedNCT06357104Phase 4
- Effects of Antipsychotics on Brain Insulin Action in FemalesActive, not recruitingNCT06251635Not applicable
- Synergistic Effect of Vitamin E & D in Reducing Risk of Effects Associated With Atypical Anti-psychoticsCompletedNCT06200584Not applicable
- Effect of Olanzapine on Opioid Craving and Misuse Among Patients Receiving Opioids for Cancer-related Pain: A Pilot Double-Blind, Randomized Control TrialActive, not recruitingNCT06200181Phase 3
- Psychopharmacological Treatment of Emotional DistressWithdrawnNCT06133114Phase 4
- Effect of Ketanserin, Olanzapine, and Lorazepam After LSD Administration on the Acute Response to LSD in Healthy SubjectsCompletedNCT05964647Phase 1
- A Study of Olanzapine in Patients With Acute AgitationStatus unknownNCT05803642Phase 3
- Olanzapine for the Treatment of Chronic Nausea and/or Vomiting in Patients With Advanced CancerWithdrawnNCT05403580Phase 3
- Low Dose Olanzapine to the Prophylaxis of Nausea and Vomiting Induced by Chemotherapy in Children and AdolescentsStatus unknownNCT05346731Phase 3